本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Catalyst Pharmaceutical Partners

21.01
-0.3500-1.64%
盤後21.010.00000.00%19:47 EDT
成交量:101.38萬
成交額:2,134.39萬
市值:25.71億
市盈率:12.75
高:21.30
開:21.16
低:20.88
收:21.36
52周最高:26.58
52周最低:19.05
股本:1.22億
流通股本:1.15億
量比:1.02
換手率:0.88%
股息:- -
股息率:- -
每股收益(TTM):1.65
每股收益(LYR):1.38
淨資產收益率:28.49%
總資產收益率:18.13%
市淨率:3.00
市盈率(LYR):15.19

資料載入中...

公司資料

公司名字:
Catalyst Pharmaceutical Partners
交易所:
NASDAQ
成立時間:
2002
員工人數:
181
公司地址:
355 Alhambra Circle,Suite 801,Coral Gables,Florida,United States
郵編:
33134
電話:
傳真:
- -
簡介:
Catalyst Pharmaceuticals, Inc.於2006年7月在特拉華州註冊成立。該公司是一家商業階段、以患者為中心的生物製藥公司,專註於為患有罕見和難以治療的疾病的患者提供新的高質量藥物的許可、開發和商業化。該公司利用協調一致的勤奮努力,尋找能夠改善那些患有罕見或難以治療的疾病的人的生活的療法。

董事

名稱
職位
Patrick J. McEnany
Non-Executive Chairman of the Board
Richard J. Daly
Director, President and Chief Executive Officer
David S. Tierney
Independent Director
Donald A. Denkhaus
Independent Director
Molly Harper
Lead Independent Director
Tamar Thompson
Independent Director
Daniel J. Curran
Director

股東

名稱
職位
Richard J. Daly
Director, President and Chief Executive Officer
Steven R. Miller
Executive Vice President, Chief Operating Officer and Chief Scientific Officer
Michael W. Kalb
Executive Vice President,Treasurer, Chief Financial Officer and Principal Accounting Officer
Brian Elsbernd
Chief Compliance Officer and Chief Legal Officer
Gary Ingenito
Chief Medical Officer and Chief Regulatory Officer
Gregg Russo
Chief Human Resources Officer
Jeffrey Del Carmen
Executive Vice President and Chief Commercial Officer
Preethi Sundaram
Chief Strategy Officer